EP Patent

EP1982701A2 — Sustained Release Drug Delivery Devices, Methods of Use, and Methods of Manufacturing Thereof

Assigned to Eyepoint Pharmaceuticals Inc · Expires 2008-10-22 · 18y expired

What this patent protects

A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained release drug delivery system to mammalian organism in need of such treatment at an area w…

USPTO Abstract

A method and device for treating a mammalian organism to obtain a desired local or systemic physiological or pharmacological effect is provided. The method includes administering a sustained release drug delivery system to mammalian organism in need of such treatment at an area wherein release of an effective agent is desired and allowing the effective agent to pass through the device in a controlled manner. The device includes an inner core or reservoir including the effective agent, an impermeable tube which encloses portions of the reservoir, and a permeable member at the end of the tube.

Drugs covered by this patent

Patent Metadata

Patent number
EP1982701A2
Jurisdiction
EP
Classification
—
Expires
2008-10-22
Drug substance claim
No
Drug product claim
No
Assignee
Eyepoint Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.